- Drugs
- Feed Products
Aquaculture refers to the breeding, rearing, and harvesting of aquatic organisms such as aquatic plants, fishes, and other animals in the lakes, ponds, rivers, and oceans. Aquaculture healthcare is considered as an essential part to prevent or cure the various diseases such as injuries, parasitic diseases, bacterial, viral, and fungal infections among others. Aquaculture healthcare is an essential part of the herd management to reduce the loss of aquatic products due to various diseases.
Middle East and Africa Aquaculture Healthcare Market Dynamics
Rise in aquaculture farming in African countries and development in economic growth. Adoption of newer diagnostic tests and therapeutics for aquacultureand government support for the protection of aquatic animal health and Rise in prevalence of various diseases due to rise in water pollutionand expansion of business by market players
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Middle East And Africa Aquaculture Healthcare Market Segmentation
By Product Type
By Species Type
- Salmon
- Sturgeon
- Turbot
- Carp
- Sea bass
- Trout
- Others
By Disease Type
- Viral Infections
- Bacterial Infections
- Parasitic Infection
- Fungal Infections
By Route of Administration
- Oral
- Parenteral
- Immersion
- Spray
By Distribution Channel
- Veterinary Hospitals
- Veterinary Pharmacies
- Online Pharmacies
By country
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
Zoetis (Pfizer, Inc.) (U.S.), Archer Daniels Midland Company (U.S.), Virbac S.A. (France), Merck & Co. Inc. (U.S), Bayer Animal Health (Germany), Elanco (U.S.), Alltech (U.S.)
Middle East and Africa aquaculture healthcare Market is projected to expand at a CAGR of X% during the forecast period.
| 1.Executive Summary |
| 2. Middle East and Africa Aquaculture Healthcare Market Introduction |
| 2.1. Middle East and Africa Aquaculture Healthcare Market - Taxonomy |
| 2.2. Middle East and Africa Aquaculture Healthcare Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Species Type |
| 2.2.3.Disease Type |
| 2.2.4.Route of Administration |
| 2.2.5.Region |
| 3. Middle East and Africa Aquaculture Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East and Africa Aquaculture Healthcare Market Analysis, 2019-2024 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East and Africa Aquaculture Healthcare Market By Product Type, 2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Drugs |
| 5.1.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Feed Products |
| 5.2.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Middle East and Africa Aquaculture Healthcare Market By Species Type, 2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Salmon |
| 6.1.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Sturgeon |
| 6.2.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Turbot |
| 6.3.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Carp |
| 6.4.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Sea bass |
| 6.5.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Trout |
| 6.6.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Middle East and Africa Aquaculture Healthcare Market By Disease Type, 2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Viral Infections |
| 7.1.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Bacterial Infections |
| 7.2.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Parasitic Infection |
| 7.3.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Fungal Infections |
| 7.4.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Middle East and Africa Aquaculture Healthcare Market By Route of Administration, 2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Oral |
| 8.1.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Parenteral |
| 8.2.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Immersion |
| 8.3.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Spray |
| 8.4.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Middle East and Africa Aquaculture Healthcare Market By Region, 2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Gulf Cooperation Council (GCC) Countries |
| 9.1.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Israel |
| 9.2.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. South Africa |
| 9.3.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Rest of MEA |
| 9.4.1. Market Analysis, 2019-2024 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 10.Gulf Cooperation Council (GCC) Countries Aquaculture Healthcare Market ,2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drugs |
| 10.1.2.Feed Products |
| 10.2. Species Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Salmon |
| 10.2.2.Sturgeon |
| 10.2.3.Turbot |
| 10.2.4.Carp |
| 10.2.5.Sea bass |
| 10.2.6.Trout |
| 10.2.7.Others |
| 10.3. Disease Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Viral Infections |
| 10.3.2.Bacterial Infections |
| 10.3.3.Parasitic Infection |
| 10.3.4.Fungal Infections |
| 10.4. Route of Administration Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Oral |
| 10.4.2.Parenteral |
| 10.4.3.Immersion |
| 10.4.4.Spray |
| 10.5. Country Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.Israel Aquaculture Healthcare Market ,2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drugs |
| 11.1.2.Feed Products |
| 11.2. Species Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Salmon |
| 11.2.2.Sturgeon |
| 11.2.3.Turbot |
| 11.2.4.Carp |
| 11.2.5.Sea bass |
| 11.2.6.Trout |
| 11.2.7.Others |
| 11.3. Disease Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Viral Infections |
| 11.3.2.Bacterial Infections |
| 11.3.3.Parasitic Infection |
| 11.3.4.Fungal Infections |
| 11.4. Route of Administration Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Oral |
| 11.4.2.Parenteral |
| 11.4.3.Immersion |
| 11.4.4.Spray |
| 11.5. Country Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.South Africa Aquaculture Healthcare Market ,2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drugs |
| 12.1.2.Feed Products |
| 12.2. Species Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Salmon |
| 12.2.2.Sturgeon |
| 12.2.3.Turbot |
| 12.2.4.Carp |
| 12.2.5.Sea bass |
| 12.2.6.Trout |
| 12.2.7.Others |
| 12.3. Disease Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Viral Infections |
| 12.3.2.Bacterial Infections |
| 12.3.3.Parasitic Infection |
| 12.3.4.Fungal Infections |
| 12.4. Route of Administration Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Oral |
| 12.4.2.Parenteral |
| 12.4.3.Immersion |
| 12.4.4.Spray |
| 12.5. Country Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.Rest of MEA Aquaculture Healthcare Market ,2019-2024 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drugs |
| 13.1.2.Feed Products |
| 13.2. Species Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Salmon |
| 13.2.2.Sturgeon |
| 13.2.3.Turbot |
| 13.2.4.Carp |
| 13.2.5.Sea bass |
| 13.2.6.Trout |
| 13.2.7.Others |
| 13.3. Disease Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Viral Infections |
| 13.3.2.Bacterial Infections |
| 13.3.3.Parasitic Infection |
| 13.3.4.Fungal Infections |
| 13.4. Route of Administration Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Oral |
| 13.4.2.Parenteral |
| 13.4.3.Immersion |
| 13.4.4.Spray |
| 13.5. Country Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2. Species Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Salmon |
| 14.2.2.Sturgeon |
| 14.2.3.Turbot |
| 14.2.4.Carp |
| 14.2.5.Sea bass |
| 14.2.6.Trout |
| 14.2.7.Others |
| 14.3. Disease Type Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Viral Infections |
| 14.3.2.Bacterial Infections |
| 14.3.3.Parasitic Infection |
| 14.3.4.Fungal Infections |
| 14.4. Route of Administration Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Oral |
| 14.4.2.Parenteral |
| 14.4.3.Immersion |
| 14.4.4.Spray |
| 14.5. Country Analysis 2019-2024 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 15.2.2.Archer Daniels Midland Company (U.S.) |
| 15.2.3.Virbac S.A. (France) |
| 15.2.4.Merck & Co. Inc. (U.S) |
| 15.2.5.Bayer Animal Health (Germany) |
| 15.2.6.Elanco (U.S.) |
| 15.2.7.Alltech (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Zoetis (Pfizer, Inc.) (U.S.)
- Archer Daniels Midland Company (U.S.)
- Virbac S.A. (France)
- Merck & Co. Inc. (U.S)
- Bayer Animal Health (Germany)
- Elanco (U.S.)
- Alltech (U.S.)